Kite, a Gilead Company , presented Phase 1 data today with encouraging efficacy and safety results for its two investigational bicistronic CAR T-cell therapies, KITE-753 and KITE-363, respectively, in ...
Kite, a Gilead Company , and its partner Arcellx, today announced new positive data from its pivotal iMMagine-1 Phase 2 study of anitocabtagene autoleucel (anito-cel), an investigational agent, which ...
21hOpinion
Weekly Commentary: $12 TN And Counting
Money Market Fund Assets surged $132 billion last week to a record $7.654 TN - the largest increase since the week ended ...
Willow Bend Environmental Education Center, 703 E. Sawmill Road, Flagstaff. 928-779-1745. 9:30-11:30 a.m., Embrace the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback